Innovation Fund America is a nonprofit that works to accelerate early stage technology startups through funding and education in Northeast Ohio. In late September, Innovation Fund America awarded pre-seed funding to 5 technology startups for between $25,000 and $50,000 to continue their growth by testing products, hiring employees, or improving their products.
Markers, a 2016 Flashstarts Portfolio company founded by finance expert Reginald Cash, was a recipient of GLIDE Innovation funding ($50,000). Markers is an enterprise software application that allows publicly listed companies have more fluid conversations with their internal and external stakeholders.
A company that has a shorter time-to-information can attract, engage and convert more institutional investors and potential shareholders. Markers provides a knowledge repository that is the first step towards achieving the premium available to any publicly listed company.
According to Cash, “at Markers, [we] believe a shorter time to information is the key to unlocking investor relations ‘alpha’. A company that has a shorter time-to-information can attract, engage and convert more institutional investors and potential shareholders. Markers provides a knowledge repository, a single point of entry for content. It is the first step towards achieving the premium available to any publicly listed company.”
Markers plans to use the funding from the Innovation Fund America to help the company further automate and streamline its on-boarding approach.
The other companies that received an award from the Innovation Fund America include (as written in the Innovation Fund press release) :
Sell Hack ($50,000 | Chardon) is a platform built for sales professionals who want to spend more time closing deals and less time finding leads, building lists and guessing emails. The company will use the money for product development, marketing, and key hires.
Trailhead Biosystems ($25,000 | Cleveland) merges developmental biology with cutting edge hardware, and computerized experimental design and analysis to develop optimized cell therapy recipes. Trailhead is using the money to enhance its software’s capabilities and replace its manual analysis.
Ocellus Vision Therapy ($25,000 | Hudson) is commercializing a therapy that lets stroke and traumatic brain injury victims recover vision loss that was once considered a permanent condition. The company will use the funding to begin FDA approval.
Wisr ($25,000 | Rocky River) is an online solution founded by education technology veterans to engage untapped alumni by allowing students to create and curate a personal board of career advisors. The funding will help Wisr move into the beta phase of its software and to get feedback from pilot clients.